Activities

• 

  Mary Grace N. Tamio   

  on January 06 2022 at 03:40 PM Edited public

  Relatlimab plus nivolumab improves progression-free survival in metastatic melanoma
  
  #relatimab #nivolumab #melanoma
  
  For more information | ⬇️
  https://cn1699.com/news/relatlimab-plus-nivolumab-improves-progression-free-survival-metastatic-melanoma

  

  Relatlimab plus nivolumab improves progression-free survival in metastatic melanoma | CN1699

  In patients with untreated, advanced melanoma, the combination of immune checkpoint inhibitors relatlimab and nivolumab doubled the...
  0 0 0 0 0 0 0

  comment Comment

  thumb_upLike

  share Share